Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HCW3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.362 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.330 |
CLV_PCSK_FUR_1 | 121 | 125 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.375 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.345 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.325 |
DEG_APCC_DBOX_1 | 99 | 107 | PF00400 | 0.452 |
DEG_APCC_KENBOX_2 | 95 | 99 | PF00400 | 0.472 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.703 |
DOC_CYCLIN_yCln2_LP_2 | 83 | 86 | PF00134 | 0.457 |
DOC_PP2B_LxvP_1 | 83 | 86 | PF13499 | 0.447 |
DOC_PP4_FxxP_1 | 33 | 36 | PF00568 | 0.471 |
DOC_USP7_MATH_1 | 61 | 65 | PF00917 | 0.197 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.308 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.329 |
LIG_LIR_Gen_1 | 73 | 84 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.555 |
LIG_LIR_Nem_3 | 29 | 34 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 73 | 79 | PF02991 | 0.322 |
LIG_NRBOX | 148 | 154 | PF00104 | 0.460 |
LIG_PCNA_TLS_4 | 48 | 55 | PF02747 | 0.619 |
LIG_SH2_STAP1 | 28 | 32 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.580 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.618 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.305 |
LIG_TRFH_1 | 32 | 36 | PF08558 | 0.610 |
LIG_TYR_ITSM | 71 | 78 | PF00017 | 0.322 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.197 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.403 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.430 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.599 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.351 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.429 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.572 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.336 |
MOD_PKA_2 | 56 | 62 | PF00069 | 0.496 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.424 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.626 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.526 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.397 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.286 |
MOD_SUMO_for_1 | 122 | 125 | PF00179 | 0.328 |
TRG_DiLeu_BaEn_1 | 101 | 106 | PF01217 | 0.445 |
TRG_DiLeu_BaEn_4 | 144 | 150 | PF01217 | 0.388 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.279 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.476 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.566 |
TRG_ER_diArg_1 | 45 | 47 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.686 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZH6 | Leptomonas seymouri | 80% | 100% |
A0A0S4JBZ8 | Bodo saltans | 38% | 99% |
A0A1X0NWU3 | Trypanosomatidae | 57% | 100% |
A0A3Q8IBS8 | Leishmania donovani | 88% | 100% |
A0A422N7L6 | Trypanosoma rangeli | 57% | 100% |
A4I0E3 | Leishmania infantum | 88% | 100% |
C9ZV92 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9AWA6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4QB69 | Leishmania major | 89% | 100% |